| Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults (NCT02272049) | Children's Hospital Medical Center, Cincinnati | 2014-12-01 |
| BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis (NCT01598857) | Anthera Pharmaceuticals | 2014-12-01 |
| Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis (NCT01968382) | Virginia Commonwealth University | 2014-12-01 |
| Efficacy of Favipiravir Against Ebola (JIKI) (NCT02329054) | Institut National de la Santé Et de la Recherche Médicale, France | 2014-12-01 |
| The Efficacy and Safety of Retreatment With TAI for Patients Who Showed TACE-resistant: a Randomized Controlled Trial (NCT02220088) | Sun Yat-sen University | 2014-12-01 |
| Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD) (NCT01920555) | Massachusetts General Hospital | 2014-12-01 |
| Interest of COLchicine in the Treatment of Patients With Acute Myocardial INfarction and With Inflammatory Response (NCT02363725) | University Hospital, Montpellier | 2014-12-01 |
| Vemurafenib Plus Cobimetinib in Metastatic Melanoma (NCT02414750) | Netherlands Working Group on Immunotherapy of Oncology | 2014-12-01 |
| A Study of Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI) (NCT02784002) | Summit Therapeutics | 2014-12-01 |
| A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® (NCT02007356) | University Hospital, Basel, Switzerland | 2014-12-01 |
| Everolimus trIal for Advanced prememopausaL Breast Cancer Patients (NCT02313051) | Chinese Academy of Medical Sciences | 2014-12-01 |
| Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma (NCT01531244) | Washington University School of Medicine | 2014-12-01 |
| Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies (NCT02315118) | National University Hospital, Singapore | 2014-12-01 |
| Pilot Efficacy and Safety Study of AQX-1125 in Atopic Dermatitis (NCT02324972) | Aquinox Pharmaceuticals (Canada) Inc. | 2014-12-01 |
| Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib (NCT02294357) | Oncotherapeutics | 2014-12-01 |
| Neoadj ph 2 AI Plus Everolimus in Postmenopausal Women w/ ER Pos/HER2 Neg, Low Risk Score (NCT02236572) | Yale University | 2014-11-29 |
| Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma (NCT02169609) | Fundació Sant Joan de Déu | 2014-11-26 |
| Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease (NCT02322021) | Eisai Inc. | 2014-11-26 |
| A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) (NCT02327078) | Incyte Corporation | 2014-11-26 |
| High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery (NCT02203604) | CINJRegulatory | 2014-11-26 |
| PPALM-Palm Oil and Pentoxifylline Against Late Morbidity (NCT02230800) | Royal Marsden NHS Foundation Trust | 2014-11-25 |
| Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea (NCT02257918) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-11-25 |
| Phase II Study of Everolimus Beyond Progression (NCT02269670) | Emory University | 2014-11-25 |
| Dextromethorphan in Chemotherapy-induced Peripheral Neuropathy Management (NCT02271893) | University Hospital, Clermont-Ferrand | 2014-11-25 |
| Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer (NCT02267603) | National Cancer Institute (NCI) | 2014-11-25 |
| Evaluation of LUM001 in the Reduction of Pruritus in Alagille Syndrome (NCT02057692) | Mirum Pharmaceuticals, Inc. | 2014-11-24 |
| A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy (NCT02310763) | Pfizer | 2014-11-24 |
| Efficacy and Safety Study of WTX101 (ALXN1840) in Adult Wilson Disease Patients (NCT02273596) | Alexion Pharmaceuticals, Inc. | 2014-11-24 |
| Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users (NCT02342470) | PharmaKing | 2014-11-24 |
| Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver (NCT02273362) | National Cancer Institute (NCI) | 2014-11-24 |
| Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL) (NCT01924169) | M.D. Anderson Cancer Center | 2014-11-24 |
| Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules (NCT02169271) | National Cancer Institute (NCI) | 2014-11-21 |
| Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies (NCT02333058) | medac GmbH | 2014-11-21 |
| Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia (NCT02298933) | National Heart, Lung, and Blood Institute (NHLBI) | 2014-11-21 |
| Efficacy of LAMA Added to ICS in Treatment of Asthma (ELITRA) (NCT02296411) | Chiesi Farmaceutici S.p.A. | 2014-11-21 |
| Treatment of Iron Overload Requiring Chelation Therapy (NCT01927913) | Shire | 2014-11-20 |
| Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL) (NCT02301364) | Memorial Sloan Kettering Cancer Center | 2014-11-20 |
| Mesenchymal Stromal Cells for the Treatment of Non-union Fractures of Long Bones (NCT02230514) | Banc de Sang i Teixits | 2014-11-20 |
| Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis (NCT02203851) | AbbVie | 2014-11-20 |
| Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine (NCT02270944) | GlaxoSmithKline | 2014-11-20 |
| Stimulation of the Efferent Loop Before Loop Ileostomy Closure (NCT03424447) | Hospital de Basurto | 2014-11-20 |
| Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded). (NCT02273661) | Poitiers University Hospital | 2014-11-19 |
| Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma (NCT02068586) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2014-11-19 |
| MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantation (NCT02250300) | Mehdi Hamadani | 2014-11-19 |
| Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOP (NCT02049866) | Elizabeth Shane | 2014-11-19 |
| Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction (NCT02275338) | Ipsen | 2014-11-19 |
| Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC) (NCT02667574) | University Hospital, Lille | 2014-11-18 |
| Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide (NCT02312557) | OHSU Knight Cancer Institute | 2014-11-18 |
| An Extension of Protocol PRO 140_CD01 Study (NCT02355184) | CytoDyn, Inc. | 2014-11-18 |
| A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis (NCT02295865) | Janssen Research & Development, LLC | 2014-11-17 |
| Study to Evaluate Safety and Efficacy in Adult Subjects With ITP (NCT02273960) | Bristol-Myers Squibb | 2014-11-17 |
| Very Low Nicotine Cigarettes in Smokers With Schizophrenia (NCT02019459) | Brown University | 2014-11-17 |
| Automated Administration of Fluids Guided by Dynamic Parameters and Cardiac Output During General Anesthesia (NCT02138942) | Centre Hospitalier Universitaire de Nīmes | 2014-11-17 |
| Remote Alcohol Monitoring to Facilitate Abstinence Reinforcement: Feasibility (NCT03507075) | Mikhail Koffarnus | 2014-11-15 |
| BMS-986012 in Relapsed/Refractory SCLC (NCT02247349) | Bristol-Myers Squibb | 2014-11-14 |
| Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT02283658) | Mayo Clinic | 2014-11-14 |
| Selinexor in Initial or Refractory and/or Relapsed Richter's Transformation (NCT02138786) | Karyopharm Therapeutics Inc | 2014-11-14 |
| A Phase 2A Study of ALXN1007 in Participants With Newly Diagnosed Acute Lower Gastrointestinal Graft-Versus-Host Disease (NCT02245412) | Alexion Pharmaceuticals, Inc. | 2014-11-14 |
| Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus (NCT02265744) | Bristol-Myers Squibb | 2014-11-13 |
| 3 Adjuvated Reduced Dose IPV-Al SSI Vaccines and Non-adjuvated Full Dose IPV SSI, as Booster Vaccination to Adolescents (NCT02280447) | Statens Serum Institut | 2014-11-13 |
| Lenalidomide in Treating Patients With High Risk Acute Myeloid Leukemia in Remission (NCT02126553) | M.D. Anderson Cancer Center | 2014-11-13 |
| Single-arm Study of Selumetinib in Combination With Docetaxel, in Advanced Gastric Adenocarcinoma Patients With Low/High MEK Signature, RAS Mutation or RAS Amplification as a Second-line Chemotherapy (NCT02448290) | Samsung Medical Center | 2014-11-12 |
| A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI) (NCT02273973) | Genentech, Inc. | 2014-11-12 |
| Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB (NCT01751568) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-11-12 |
| Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis. (NCT02132026) | University of Edinburgh | 2014-11-12 |
| Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06) (NCT01936532) | Nantes University Hospital | 2014-11-12 |
| DLBS1033 for Acute Ischemic Stroke Patients (NCT02133521) | Dexa Medica Group | 2014-11-11 |
| Sildenafil for Treatment of Choroidal Ischemia (NCT04356716) | Columbia University | 2014-11-11 |
| Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma (NCT02243436) | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 2014-11-11 |
| Comparing Minisling to Tension Free Vaginal Tape in Mangement of Stress Urinary Incontinence (NCT02263534) | Ain Shams University | 2014-11-10 |
| Guadecitabine in Treating Patients With Higher-Risk Myelodysplastic Syndromes (NCT02131597) | M.D. Anderson Cancer Center | 2014-11-10 |
| A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN) (NCT02215252) | Pfizer | 2014-11-10 |
| A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment. (NCT02281773) | Boehringer Ingelheim | 2014-11-10 |
| A Phase Ib/2 Clinical Study of Fruquintinib Combined With Paclitaxel in the Treatment of Advanced Gastric Cancer (NCT02415023) | Hutchison Medipharma Limited | 2014-11-09 |
| A Study Evaluating the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Participants With Uncontrolled Asthma (NCT02099656) | Hoffmann-La Roche | 2014-11-06 |
| Stereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal Spacer (NCT02353832) | University of Texas Southwestern Medical Center | 2014-11-06 |
| Phase II Study With Ga101-DHAP as Induction Therapy in Relapsed/Refractory DLBCL Patients (NCT02374424) | Fondazione Italiana Linfomi - ETS | 2014-11-05 |
| Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years Old (NCT02221674) | Grünenthal GmbH | 2014-11-05 |
| Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination +/- Ribavirin in Adolescents and Children With Chronic HCV-Infection (NCT02249182) | Gilead Sciences | 2014-11-05 |
| Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases (NCT02374242) | Melanoma Institute Australia | 2014-11-04 |
| Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered in Participants With B-cell NHL (NCT02151903) | Alopexx Oncology, LLC | 2014-11-04 |
| Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH) (NCT02039219) | Naga P. Chalasani | 2014-11-03 |
| Vandetanib in Advanced NSCLC With RET Rearrangement (NCT01823068) | Samsung Medical Center | 2014-11-03 |
| Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies (NCT02222545) | Omeros Corporation | 2014-11-02 |
| Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated Pain (NCT02452112) | Mundipharma (China) Pharmaceutical Co. Ltd | 2014-11-02 |
| Optimising Renal Outcome in Myeloma Renal Failure (NCT02424851) | Oxford University Hospitals NHS Trust | 2014-11-01 |
| S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer (NCT02164916) | SWOG Cancer Research Network | 2014-11-01 |
| Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients (NCT02471820) | Meletios A. Dimopoulos | 2014-11-01 |
| A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (NCT02326454) | Light Sciences Oncology | 2014-11-01 |
| A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies (NCT01798745) | Janssen Research & Development, LLC | 2014-11-01 |
| In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer (NCT01923233) | Mirror Biologics, Inc. | 2014-11-01 |
| Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients (NCT02415829) | Fudan University | 2014-11-01 |
| POC Study in Partially Responsive Generalized Anxiety Disorder (NCT02310568) | Pfizer | 2014-11-01 |
| High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases (NCT02284490) | Rongjie Tao | 2014-11-01 |
| Effect of Ursolic Acid of Loquat Extract on Function of Muscle (NCT02401113) | Pusan National University Hospital | 2014-11-01 |
| A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer (NCT02151084) | University Health Network, Toronto | 2014-11-01 |
| Neuromuscular Magnetic Stimulation in ALS Patients (NCT03618966) | University of Roma La Sapienza | 2014-11-01 |
| Effects of Magnetic Therapy and Seawater Combined in Decreasing Intraocular Presion. (NCT02300818) | American Society Of Thermalism And Climatology Inc | 2014-11-01 |
| Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO (NCT02006147) | Taiwan Liposome Company | 2014-11-01 |
| Autologous Endothelial Progenitor Cells Transplantation for Chronic Ischemic Stroke (NCT02605707) | Southern Medical University, China | 2014-11-01 |